These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome. van den Bergh PJ, Kievit PC, Brouwer MA, Aengevaeren WR, Veen G, Verheugt FW. Am Heart J; 2009 Mar; 157(3):532-40. PubMed ID: 19249425 [Abstract] [Full Text] [Related]
5. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial. Brouwer MA, van den Bergh PJ, Aengevaeren WR, Veen G, Luijten HE, Hertzberger DP, van Boven AJ, Vromans RP, Uijen GJ, Verheugt FW. Circulation; 2002 Aug 06; 106(6):659-65. PubMed ID: 12163424 [Abstract] [Full Text] [Related]
6. Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling. Meijer A, Verheugt FW, van Eenige MJ, Werter CJ. Circulation; 1994 Oct 06; 90(4):1706-14. PubMed ID: 7923654 [Abstract] [Full Text] [Related]
7. Improvement in three-month angiographic outcome suggested after primary angioplasty for acute myocardial infarction (Zwolle trial) compared with successful thrombolysis (APRICOT trial). Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis. Veen G, de Boer MJ, Zijlstra F, Verheugt FW. Am J Cardiol; 1999 Oct 01; 84(7):763-7. PubMed ID: 10513770 [Abstract] [Full Text] [Related]
8. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study. Meijer A, Verheugt FW, Werter CJ, Lie KI, van der Pol JM, van Eenige MJ. Circulation; 1993 May 01; 87(5):1524-30. PubMed ID: 8491007 [Abstract] [Full Text] [Related]
9. Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis. Veen G, Meyer A, Verheugt FW, Werter CJ, de Swart H, Lie KI, van der Pol JM, Michels HR, van Eenige MJ. J Am Coll Cardiol; 1993 Dec 01; 22(7):1755-62. PubMed ID: 8245325 [Abstract] [Full Text] [Related]
12. Long-term implications of reocclusion on left ventricular size and function after successful thrombolysis for first anterior myocardial infarction. Nijland F, Kamp O, Verheugt FW, Veen G, Visser CA. Circulation; 1997 Jan 07; 95(1):111-7. PubMed ID: 8994425 [Abstract] [Full Text] [Related]
13. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy. White HD, French JK, Hamer AW, Brown MA, Williams BF, Ormiston JA, Cross DB. J Am Coll Cardiol; 1995 Jan 07; 25(1):218-23. PubMed ID: 7798505 [Abstract] [Full Text] [Related]
19. Inverse relation between diastolic blood pressure and long-term outcomes in patients undergoing pharmacoinvasive therapy for myocardial infarction: the J-shaped relation in the contemporary era of revascularisation. Lee CH, Foo D, Wong HB, Hong EC, Seow SC, Ng KS, Lim YT, Tan HC. J Cardiovasc Med (Hagerstown); 2006 Nov 07; 7(11):806-11. PubMed ID: 17060806 [Abstract] [Full Text] [Related]
20. Long-term prognosis of patency of infarct-related coronary artery after thrombolytic treatment in acute myocardial infarction. Collaborative Research Group on Thrombolysis. Chin Med J (Engl); 1997 Mar 07; 110(3):191-4. PubMed ID: 9594338 [Abstract] [Full Text] [Related] Page: [Next] [New Search]